Amalgamated Bank reduced its position in MetLife, Inc. (NYSE:MET – Free Report) by 3.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 111,781 shares of the financial services provider’s stock after selling 4,089 shares during the quarter. Amalgamated Bank’s holdings in MetLife were worth $9,153,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. MeadowBrook Investment Advisors LLC lifted its stake in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. raised its holdings in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 186 shares during the period. Peterson Financial Group Inc. purchased a new position in shares of MetLife in the third quarter valued at about $30,000. Retirement Wealth Solutions LLC bought a new position in shares of MetLife in the fourth quarter worth about $32,000. Finally, Sierra Ocean LLC purchased a new stake in shares of MetLife during the fourth quarter worth about $32,000. 94.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts recently commented on MET shares. JPMorgan Chase & Co. boosted their price target on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. BMO Capital Markets started coverage on shares of MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 target price on the stock. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Keefe, Bruyette & Woods decreased their price target on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 12th. Finally, Wells Fargo & Company raised their price objective on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $92.58.
MetLife Stock Up 1.3 %
Shares of NYSE:MET opened at $82.29 on Wednesday. The company has a 50-day moving average price of $83.41 and a 200 day moving average price of $81.69. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 12 month low of $67.30 and a 12 month high of $89.05. The company has a market cap of $56.98 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 0.65 and a beta of 1.07.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, equities research analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.65%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio (DPR) is 36.52%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What Are Some of the Best Large-Cap Stocks to Buy?
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Find and Profitably Trade Stocks at 52-Week Lows
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What Are Earnings Reports?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.